Brachytherapy
Volume 8, Issue 3 , Pages 313-317 , July 2009

Endoscopic brachytherapy for obstructive colorectal cancer

  • Tiffany Y. Tam

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, 699 Concession Street, Hamilton, ON L8V 5C2, Canada. Tel.: +1-905-387-9495; fax: +1-905-575-6326.
    • ,
  • Som Mukherjee

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Tom Farrell

      Affiliations

    • Department of Medical Physics, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • David Morgan

      Affiliations

    • Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Ranjan Sur

      Affiliations

    • Department of Oncology, Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada
    • Department of Medicine, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada

References 

  1. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics; 2007:38–41.
  2. Hoskin PJ, de Canha SM, Bownes P, et al. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiother Oncol. 2004;73:195–198
  3. Celebioglu B, Gurkan OU, Erdogan S, et al. High dose rate endoluminal brachytherapy effectively palliated symptoms due to inoperable lung cancer. Jpn J Clin Oncol. 2002;32:443–448
  4. Sur R, Donde B, Falkson C, et al. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy. 2004;3:191–195
  5. Mallick I, Sharma SC, Behera D. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer—Analysis of symptom response, endoscopic improvement and quality of life. Lung Cancer. 2007;55:313–318
  6. Sur RK, Levin CV, Donde B, et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma—An International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127–133
  7. Kuehne J, Kleisli T, Biernacki P, et al. Use of high-dose-rate brachytherapy in the management of locally recurrent rectal cancer. Dis Colon Rectum. 2003;46:895–899
  8. Wodnicki H, Goldberg R, Kaplan S, et al. The laser: An alternative for palliative treatment of obstructing intraluminal lesions. Am Surg. 1998;54:227–230
  9. Adler DG, Baron TH. Endoscopic palliation of colorectal cancer. Hematol Oncol Clin North Am. 2002;16:1015–1029
  10. Kozarek RA, Brandabur JJ, Raltz SL. Expandable stents: Unusual locations. Am J Gastroenterol. 1997;92:812–815
  11. Im JP, Kim SG, Kang HW, et al. Clinical outcomes and patency of self-expanding metal stents in patients with malignant colorectal obstruction: A prospective single center study. Int J Colorectal Dis. 2008;23:789–794
  12. Mischinger HJ, Hauser H, Cerwenka H. Endocavitary Ir-192 radiation and laser treatment for palliation of obstructive rectal cancer. Eur J Surg Oncol. 1997;23:428–431
  13. Conio M, Picasso M, Orsatti M. Combined treatment with laser therapy (Nd:YAG) and endocavitary radiation in the palliation of rectal cancer. Hepatogastroenterology. 1996;43:1518–1522
  14. Rubin P, Casarett GW. Concepts of clinical radiation pathology. In: Dalrymple  editors. Medical radiation biology. Toronto, ON: WB Saunders Co; 1973;p. 160–189
  15. Rubin P, Casarett GW. A direction for clinical radiation pathology: The tolerance dose. In:  Vaeth J editors. Frontiers of radiation therapy and oncology. Vol. 6:Baltimore, MD: Karger, Basel, and University Park Press; 1972;p. 13
  16. Friedman M. Calculated risks of radiation injury of normal tissue in the treatment of cancer of the testes. Proc 2nd Nat Cancer Conf. 1952;1:390
  17. Hall EJ, Giaccia AJ. Radiobiology for the radiologist. Philadelphia, PA: Lippincott Williams & Wilkins Publishers; 2005;pp. 391

PII: S1538-4721(08)00702-2

doi: 10.1016/j.brachy.2008.12.003

Brachytherapy
Volume 8, Issue 3 , Pages 313-317 , July 2009

Article Tools

* Image Usage & Resolution